These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7912486)

  • 1. Soluble guanylyl cyclase and platelet function.
    Buechler WA; Ivanova K; Wolfram G; Drummer C; Heim JM; Gerzer R
    Ann N Y Acad Sci; 1994 Apr; 714():151-7. PubMed ID: 7912486
    [No Abstract]   [Full Text] [Related]  

  • 2. Synergism between nitric oxide and hydrogen peroxide in the inhibition of platelet function: the roles of soluble guanylyl cyclase and vasodilator-stimulated phosphoprotein.
    Sabetkar M; Naseem KM; Tullett JM; Friebe A; Koesling D; Bruckdorfer KR
    Nitric Oxide; 2001 Jun; 5(3):233-42. PubMed ID: 11384196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for the inhibitory role of guanosine 3', 5'-monophosphate in ADP-induced human platelet aggregation in the presence of nitric oxide and related vasodilators.
    Mellion BT; Ignarro LJ; Ohlstein EH; Pontecorvo EG; Hyman AL; Kadowitz PJ
    Blood; 1981 May; 57(5):946-55. PubMed ID: 6111365
    [No Abstract]   [Full Text] [Related]  

  • 4. Soluble guanylyl cyclase is the only enzyme responsible for cyclic guanosine monophosphate synthesis in human platelets.
    Gambaryan S; Subramanian H; Rukoyatkina N; Herterich S; Walter U
    Thromb Haemost; 2013 May; 109(5):973-5. PubMed ID: 23467662
    [No Abstract]   [Full Text] [Related]  

  • 5. Activation of soluble guanylate cyclase by nitrovasodilators is inhibited by oxidized low-density lipoprotein.
    Schmidt K; Graier WF; Kostner GM; Mayer B; Kukovetz WR
    Biochem Biophys Res Commun; 1990 Oct; 172(2):614-9. PubMed ID: 1978674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation of cGMP-dependent and -independent nitric oxide effects on platelet apoptosis and reactive oxygen species production using platelets lacking soluble guanylyl cyclase.
    Rukoyatkina N; Walter U; Friebe A; Gambaryan S
    Thromb Haemost; 2011 Nov; 106(5):922-33. PubMed ID: 21800013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An L-arginine/nitric oxide pathway present in human platelets regulates aggregation.
    Radomski MW; Palmer RM; Moncada S
    Proc Natl Acad Sci U S A; 1990 Jul; 87(13):5193-7. PubMed ID: 1695013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of nitric oxide/cGMP system in platelet function].
    Inoue N
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():500-4. PubMed ID: 15506436
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhaled nitric oxide decreases pulmonary soluble guanylate cyclase protein levels in 1-month-old lambs.
    Thelitz S; Bekker JM; Ovadia B; Stuart RB; Johengen MJ; Black SM; Fineman JR
    J Thorac Cardiovasc Surg; 2004 May; 127(5):1285-92. PubMed ID: 15115984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The beta2 subunit inhibits stimulation of the alpha1/beta1 form of soluble guanylyl cyclase by nitric oxide. Potential relevance to regulation of blood pressure.
    Gupta G; Azam M; Yang L; Danziger RS
    J Clin Invest; 1997 Sep; 100(6):1488-92. PubMed ID: 9294115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of human platelet aggregation by S-nitrosothiols. Heme-dependent activation of soluble guanylate cyclase and stimulation of cyclic GMP accumulation.
    Mellion BT; Ignarro LJ; Myers CB; Ohlstein EH; Ballot BA; Hyman AL; Kadowitz PJ
    Mol Pharmacol; 1983 May; 23(3):653-64. PubMed ID: 6135148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The role of thiols in the stimulation of soluble guanylate cyclase by a new class of enzyme activators generating nitric oxide].
    Belushkina NN; Riaposova IK; Severina IS
    Biull Eksp Biol Med; 1997 Jan; 123(1):39-42. PubMed ID: 9213454
    [No Abstract]   [Full Text] [Related]  

  • 13. Glyceryl trinitrate increases platelet cyclic GMP after metabolism in fibroblasts.
    Kuhn M; Otten A; Frölich JC; Förstermann U
    Eur J Pharmacol; 1991 Jul; 200(1):175-8. PubMed ID: 1685121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification of guanylate cyclase from human platelets and effect of arachidonic acid peroxide.
    Asano T; Hidaka H
    Biochem Biophys Res Commun; 1977 Oct; 78(3):910-8. PubMed ID: 20893
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of ADP-induced human platelet aggregation by a new class of soluble guanylate cyclase activators capable of nitric oxide generation.
    Severina IS; Belushkina NN; Grigoryev NB
    Biochem Mol Biol Int; 1994 Aug; 33(5):957-67. PubMed ID: 7987264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The activation of soluble guanylate cyclase by new NO donors as the basis of a directed search for new efficacious vasodilators and antiaggregants].
    Severina IS; Bussygina OG; Piatakova NV
    Vestn Ross Akad Med Nauk; 2000; (4):25-30. PubMed ID: 10832410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guanidine thiol--a new activator of soluble guanylate cyclase with antihypertensive and antiaggregatory properties.
    Severina IS; Bussygina OG; Belushkina NN; Grigoryev NB
    Biochem Mol Biol Int; 1995 Jul; 36(4):913-25. PubMed ID: 8528155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. YC-1 potentiates nitric oxide- and carbon monoxide-induced cyclic GMP effects in human platelets.
    Friebe A; Müllershausen F; Smolenski A; Walter U; Schultz G; Koesling D
    Mol Pharmacol; 1998 Dec; 54(6):962-7. PubMed ID: 9855623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-density lipoprotein antagonizes the inhibitory effects of oxidized low-density lipoprotein and lysolecithin on soluble guanylyl cyclase.
    Schmidt K; Klatt P; Graier WF; Kostner GM; Kukovetz WR
    Biochem Biophys Res Commun; 1992 Jan; 182(1):302-8. PubMed ID: 1346247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric oxide-independent vasodilator rescues heme-oxidized soluble guanylate cyclase from proteasomal degradation.
    Meurer S; Pioch S; Pabst T; Opitz N; Schmidt PM; Beckhaus T; Wagner K; Matt S; Gegenbauer K; Geschka S; Karas M; Stasch JP; Schmidt HH; Müller-Esterl W
    Circ Res; 2009 Jul; 105(1):33-41. PubMed ID: 19478201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.